Laurus Labs informs about disclosure

15 Jun 2023 Evaluate

Further to intimation dated February 10, 2023, on the Inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facility Unit–2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh from 6th February, 2023 to 10th February, 2023, Laurus Labs has informed that the Company has received the Establishment Inspection Report (EIR) from USFDA.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

512.45 23.40 (4.78%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.